Cancer BiologyFrontiers in ImmunologyPeer-reviewed
Antigen presentation by clonally diverse CXCR5+ B cells to CD4 and CD8 T cells is associated with durable response to immune checkpoint inhibitors.
L. Ding, L. Sun, M. T. Bu…·W. HUGO
This study identifies that clonally diverse CXCR5+ B cells enhance IFNγ pathway activity and CD8 T cell responses, leading to durable ICI therapy outcomes in melanoma.
DOI 10.3389/fimmu.2023.1176994